International Genetically Engineered Machine Competition

International Genetically Engineered Machine Competition
Name	International Genetically Engineered Machine Competition
Founded	2003
Organizer	iGEM Foundation
Location	Global
Participants	Undergraduate, Community, High School, Overgraduate teams
Website	iGEM.org

Contents

International Genetically Engineered Machine Competition

The International Genetically Engineered Machine Competition is an annual synthetic biology competition drawing students and researchers from global institutions. Teams from universities, colleges, Massachusetts Institute of Technology, Harvard University, Stanford University, University of Cambridge and from regions including Europe, North America, Asia and Africa collaborate on projects that intersect with organizations such as the iGEM Foundation, BioBricks Foundation, SynBERC, EMBO and funding bodies like the Wellcome Trust. The event culminates in presentations at forums in cities formerly including Boston, Paris, London, and San Francisco where teams interact with judges from entities like National Institutes of Health, European Molecular Biology Laboratory, Gordon and Betty Moore Foundation, Howard Hughes Medical Institute and corporations such as Genentech and Novartis.

Overview

The competition emphasizes interdisciplinary work combining expertise from institutions such as Massachusetts Institute of Technology, University of Oxford, ETH Zurich, National University of Singapore and Tsinghua University with mentorship from labs affiliated with Broad Institute, Salk Institute, Cold Spring Harbor Laboratory and Max Planck Society. Participants design, model, and build biological systems using standardized parts inspired by concepts from the BioBricks Foundation, methods taught in courses at Caltech, Yale University, University of Tokyo and McGill University. iGEM projects often address challenges cited by agencies like the United Nations, World Health Organization, European Commission and Bill & Melinda Gates Foundation. Teams present results at jamborees judged by panels including representatives from Nature Publishing Group, Science (journal), Cell Press and corporate partners such as Merck Group.

The competition originated in the early 2000s with roots at Massachusetts Institute of Technology where founders and collaborators connected to Synthetic Biology Engineering Research Center and pioneers such as members affiliated with BioBricks Foundation developed the registry of parts. Early milestones involved demonstration projects linked to laboratories at Stanford University, Harvard University, University of California, Berkeley and collaborations with consortia like iGEM Foundation and initiatives supported by the National Science Foundation and European Research Council. Expansion occurred as teams from Imperial College London, University of Melbourne, Peking University, University of Cape Town and University of São Paulo joined, and the jamboree moved among venues in Boston, Paris, Madrid and Tokyo. Over time organizational changes involved stakeholders such as Ginkgo Bioworks, SynBioBeta, Wellcome Trust, Chan Zuckerberg Initiative and academic publishers including Oxford University Press.

The competition is organized by the iGEM Foundation with governance and advisory input from board members affiliated with institutions like MIT, Harvard, University of Cambridge and philanthropic partners including Gates Foundation. Teams register from entities such as University of California, Berkeley, University of Toronto, ETH Zurich and community labs like BioCurious and DIYbio. The program includes categories influenced by curricula at Massachusetts Institute of Technology, Carnegie Mellon University, Princeton University and high school networks such as Intel International Science and Engineering Fair. Logistics coordinate with venues formerly in Boston, Paris', London and regional hubs in Singapore and Sydney with sponsors from corporations like Novozymes, Bayer, Pfizer and nonprofits including Engineers Without Borders.

Judging criteria draw on standards from scientific publishers and funding bodies such as Nature Communications, Cell Systems, National Institutes of Health grant review panels and Wellcome Trust advisory committees. Track categories include project design, safety, human practices, entrepreneurship and software, with parallels to grant programs at European Research Council, NSF CAREER awards, and incubators like Y Combinator and IndieBio. Judges often come from institutions such as Broad Institute, Salk Institute, EMBL-EBI and companies like Roche, Illumina and Thermo Fisher Scientific. Awards mirror recognitions given by academies such as the Royal Society, National Academy of Sciences and industry prizes like those from Wiley and Elsevier.

Notable projects have included biosensors inspired by research at MIT, engineered microbes with applications linked to Gates Foundation priorities, and community health initiatives echoing programs at WHO and UNICEF. Successful teams have incubated startups that partnered with Ginkgo Bioworks, Amyris, Zymergen and received investment from firms such as Sequoia Capital and Andreessen Horowitz. Technologies demonstrated at jamborees have informed research at Sanger Institute, Broad Institute, Wellcome Sanger Institute and translational programs at Stanford University School of Medicine, Johns Hopkins University and UCSF. Alumni have taken roles at organizations including Genentech, Novartis, Moderna, Illumina and research institutes like Max Planck Institute.

The competition has faced debate involving regulators and institutions such as the United States Food and Drug Administration, European Medicines Agency, World Health Organization and national biosecurity agencies. Controversies involved risk assessment frameworks discussed alongside reports from National Academies of Sciences, Engineering, and Medicine, policy reviews by the European Commission, and critiques published in journals associated with Nature and Science (journal). Discussions engaged stakeholders from DIYbio, BioBricks Foundation, SynBERC and community labs such as BioCurious about dual-use, containment, and institutional review board practices at universities including Harvard, MIT and UC Berkeley.

The competition influenced curricula at universities like MIT, University of Cambridge, ETH Zurich, and contributed to the growth of networks including SynBioBeta, BioBricks Foundation and incubators such as IndieBio. Its alumni network feeds into industry leaders like Genentech, Ginkgo Bioworks, Moderna and academic institutions including Broad Institute, Salk Institute and Max Planck Society. Policymakers at entities like the European Commission, National Institutes of Health, World Health Organization and national academies reference iGEM case studies in guidance on synthetic biology, while journals such as Nature Biotechnology and Cell publish related scholarship influenced by competition outputs.